Napanee, Ontario-based Abcann Global (TSX-V:ABCN) announced it has been licensed by Health Canada to produce medical cannabis oils. Once it has finished products, Health Canada will conduct a final inspection to approve the sales. This is expected in the first quarter of 2018.
“Receipt of the license to produce cannabis oils is a major milestone…,” commented Barry Fishman, CEO of ABcann.
ABcann’s flagship facility in Napanee, Ontario contains proprietary plant-growing technology, centered on its specially designed, environmentally-controlled growing chambers, resulting in the production of pharmaceutical-grade cannabis products.
The company is expanding its capacity and pursuing partnerships domestically, as well as in Germany, Australia and Israel.